Literature DB >> 2456805

On the adenosine receptor and adenosine inactivation at the rat diaphragm neuromuscular junction.

A M Sebastião1, J A Ribeiro.   

Abstract

1. The effects of adenosine and adenosine analogues 2-chloroadenosine (CADO), L-N6-phenylisopropyladenosine (L-PIA), D-N6-phenylisopropyladenosine (D-PIA), N6-cyclohexyladenosine (CHA) and 5'-N-ethylcarboxamide adenosine (NECA) on evoked endplate potentials (e.p.ps) and on twitch tension were investigated in innervated diaphragms of the rat. 2. Adenosine and its analogues decreased, in a concentration-dependent manner, the amplitude of both the e.p.ps and the twitch responses evoked by nerve stimulation. The order of potency in decreasing the twitch tension was CHA, L-PIA, NECA greater than D-PIA greater than CADO greater than adenosine. L-PIA was about 8 times more potent than D-PIA. Neither adenosine nor the adenosine analogues affected the twitch responses of directly stimulated tubocurarine-paralysed muscles. 3. 8-Phenyltheophylline (8-PT), theophylline and isobutylmethylxanthine (IBMX), in concentrations virtually devoid of effect on neuromuscular transmission, antagonized the inhibitory effect of 2-chloroadenosine. The order of potency of the alkylxanthines as antagonists of the adenosine receptor at the rat diaphragm neuromuscular junction was 8-PT greater than IBMX greater than theophylline. The antagonism by these xanthines was shown to be competitive, the pA2 value for 8-PT being 7.16. In concentrations slightly higher than those used to test its ability to antagonize the adenosine receptor, IBMX and 8-PT increased the amplitude of e.p.ps without modifying their decay phase or the resting membrane potential of the muscle fibre. 4. The adenosine uptake inhibitor, nitrobenzylthioinosine (NBI) and the adenosine deaminase inhibitor, erythro-9(2-hydroxy-3-nonyl)adenine (EHNA), in concentrations virtually devoid of effect on neuromuscular transmission, potentiated the inhibitory effect of adenosine at the rat diaphragm neuromuscular junction. The potentiation factors were about 2.6 for NBI (5 microM), 2.2 for EHNA (25 microM) and 4.6 for the combination of NBI (5 microM) and EHNA (25 microM). 5. It is concluded that both uptake and deamination contribute to the inactivation of adenosine at the rat diaphragm neuromuscular junction and that in this preparation the inhibitory effect of adenosine on transmission is mediated by a xanthine-sensitive adenosine receptor with an agonist profile which does not fit the criteria for its classification either as an A1 or A2-adenosine receptor.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2456805      PMCID: PMC1853929          DOI: 10.1111/j.1476-5381.1988.tb11505.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  28 in total

1.  SURVIVAL OF SHIGELLA IN SEA WATER.

Authors:  M NAKAMURA; R L STONE; J E KRUBSACK
Journal:  Nature       Date:  1964-07-11       Impact factor: 49.962

2.  Alkylxanthines: inhibition of adenosine-elicited accumulation of cyclic AMP in brain slices and of brain phosphodiesterase activity.

Authors:  F W Smellie; C W Davis; J W Daly; J N Wells
Journal:  Life Sci       Date:  1979-06-25       Impact factor: 5.037

3.  The effects of adenosine triphosphate and adenosine diphosphate on transmission at the rat and frog neuromuscular junctions.

Authors:  J A Ribeiro; J Walker
Journal:  Br J Pharmacol       Date:  1975-06       Impact factor: 8.739

4.  On the association between transmitter secretion and the release of adenine nucleotides from mammalian motor nerve terminals.

Authors:  E M Silinsky
Journal:  J Physiol       Date:  1975-05       Impact factor: 5.182

5.  Two distinct adenosine-sensitive sites on adenylate cyclase.

Authors:  C Londos; J Wolff
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

6.  Cyclic AMP, transmitter release and the effect of adenosine on neuromuscular transmission.

Authors:  B L Ginsborg; G D Hirst
Journal:  Nat New Biol       Date:  1971-07-14

7.  Tight-binding inhibitors--IV. Inhibition of adenosine deaminases by various inhibitors.

Authors:  R P Agarwal; T Spector; R E Parks
Journal:  Biochem Pharmacol       Date:  1977-03-01       Impact factor: 5.858

8.  Inhibition by nitrobenzylthioinosine of adenosine uptake by asynchronous HeLa cells.

Authors:  A R Paterson; L R Babb; J H Paran; C E Cass
Journal:  Mol Pharmacol       Date:  1977-11       Impact factor: 4.436

9.  Adenosine and cyclic AMP in rat cerebral cortical slices: effects of adenosine uptake inhibitors and adenosine deaminase inhibitors.

Authors:  Y Nimit; P Skolnick; J W Daly
Journal:  J Neurochem       Date:  1981-03       Impact factor: 5.372

10.  Guanine nucleotide and cation regulation of the binding of [3H]cyclohexyladenosine and [3H]diethylphenylxanthine to adenosine A1 receptors in brain membranes.

Authors:  R R Goodman; M J Cooper; M Gavish; S H Snyder
Journal:  Mol Pharmacol       Date:  1982-03       Impact factor: 4.436

View more
  12 in total

1.  Characterization of adenosine receptors in brush-border membranes from pig kidney.

Authors:  J Blanco; E I Canela; J Mallol; C Lluís; R Franco
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

2.  Adenosine deaminase and adenosine uptake inhibitions facilitate ventilation in rats.

Authors:  E C Monteiro; J A Ribeiro
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-08       Impact factor: 3.000

3.  The role of the A(2A) adenosine receptor subtype in functional hyperaemia in the hindlimb of anaesthetized cats.

Authors:  S M Poucher
Journal:  J Physiol       Date:  1996-04-15       Impact factor: 5.182

4.  Adenosine and adenine nucleotides are independently released from both the nerve terminals and the muscle fibres upon electrical stimulation of the innervated skeletal muscle of the frog.

Authors:  R A Cunha; A M Sebastião
Journal:  Pflugers Arch       Date:  1993-09       Impact factor: 3.657

5.  The role of adenosine in exercise hyperaemia of the gracilis muscle in anaesthetized cats.

Authors:  S M Poucher; C G Nowell; M G Collis
Journal:  J Physiol       Date:  1990-08       Impact factor: 5.182

6.  The inhibitory adenosine receptor at the neuromuscular junction and hippocampus of the rat: antagonism by 1,3,8-substituted xanthines.

Authors:  A M Sebastião; T W Stone; J A Ribeiro
Journal:  Br J Pharmacol       Date:  1990-10       Impact factor: 8.739

7.  Presynaptic A1-purinoceptor-mediated inhibitory effects of adenosine and its stable analogues on the mouse hemidiaphragm preparation.

Authors:  O Nagano; F F Földes; H Nakatsuka; D Reich; Y Ohta; B Sperlagh; E S Vizi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-08       Impact factor: 3.000

8.  Endogenous adenosine modulation of 22Na uptake by rat brain synaptosomes.

Authors:  Joaquim Alexandre Ribeiro; M Graça B Lobo; Ana M Sebastião
Journal:  Neurochem Res       Date:  2003-10       Impact factor: 3.996

9.  1,3,8- and 1,3,7-substituted xanthines: relative potency as adenosine receptor antagonists at the frog neuromuscular junction.

Authors:  A M Sebastião; J A Ribeiro
Journal:  Br J Pharmacol       Date:  1989-01       Impact factor: 8.739

10.  Activation of P1- and P2Y-purinoceptors by ADP-ribose in the guinea-pig taenia coli, but not of P2X-purinoceptors in the vas deferens.

Authors:  C H Hoyle; G A Edwards
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.